Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Slides:



Advertisements
Similar presentations
Ask your patients about tobacco use. Act to help them quit.
Advertisements

A Basic Tobacco Cessation Protocol: ASK ADVISE REFER In Collaboration With: Rx for Change is copyright © The Regents of the University of California,
Medicaid & Tobacco Dependence Treatment Mental Health and Substance Abuse Adult smoking among Medicaid recipients is 50 percent higher than the adult population.
Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Why Bother? It’s in Your Head Slay the Dragon Talk.
Nurses’ Role with Clients/Patients Who Use Tobacco Created by the Registered Nurses’ Association of Ontario.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.
Tobacco Cessation: How to Quit! Carol Southard, RN, MSN Tobacco Treatment Specialist
Smoking Cessation: A Practical Overview of Pharmacotherapy Joseph Saseen, Pharm.D., FCCP, BCPS Professor University of Colorado
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
Practical Smoking Cessation Allan Prochazka, M.D., M.Sc. Denver VAMC.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
Module 2 - Assessment, Diagnosis, and Pharmacotherapy: Integrating Tobacco Use Interventions into Chemical Dependence Services.
Pharmacotherapy of Tobacco Cessation Medications.
Quitting Smoking How to stop smoking … for good!.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
2010 PHS Clinical Practice Guidelines: Smoking Cessation CDR Sherri Yoder PharmD, BCPS, CER Program Principal Consultant Indian Health Service USPHS COA.
1 Smoking Cessation Presented by CIGNA Employee Assistance Program Copyright 2008 CIGNA HealthCare – Confidential & Privileged – Not for Distribution.
Nicotine-related disorders Answers obtained from DSM-IV-TR and the AJP Supplement of August, 2006, on substance abuse As of 1Sep08.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Smoking Cessation: the pharmacotherapeutic and non-pharmacotherapeutic approaches to addictive behavior Andrea C. McKean February 22, 2007.
Quit For Life® Program Presented by Helen Farid 1.
Review for Medical Staff, Naval Hospital Camp Pendleton Slides developed by CAPT M Ryan; Approved for Distribution and Training via ECOMS Varenicline (Chantix)
Tobacco Use and Dependence Guideline Update 2011 Annual South Texas Oral Health Network Summer Meeting August 5 th, Carlos Roberto Jaén, MD, PhD,
An Updated Algorithm for Choosing Among Smoking Cessation Treatments John R. Hughes University of Vermont, USA
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
NICOTINE LOZENGE Commit (GlaxoSmithKline); generics Nicotine polacrilex formulation Delivers ~25% more nicotine than equivalent gum dose Sugar-free, mint.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Types of help Available NHS Stop Smoking Services Nicotine Replacement Therapy (NRT) Other Pharmacological Treatments (non nicotine) Alternative Therapies.
1 Treating Nicotine Dependency Paul Zemann Public Health - Seattle & King County Tobacco Prevention Program th Ave, Suite 900 Seattle, WA 98104
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
Smoking cessation Supporting customers to quit. What you need to know PSA Presentation text 2 Discuss the health risks associated with smoking, and the.
Pharmacotherapy for Smoking Cessation
Conclusions and Awards
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
Smoking Cessation Medication
TOBACCO AND SMOKING CESSATION
Anita R. Webb, PhD JPS Family Medicine Residency
screening, brief intervention, and referral to treatment
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
Development and Implementation of a Tobacco Cessation Toolkit
Why and How to Quit Smoking
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing.
Tobacco Cessation Guidelines for COPD
Treating Tobacco Dependence
Nicotine Dependence and Treatment
ABCs of Behavioral Support
Mini Lesson #1 – Smoking Cessation
Tobacco Cessation for Primary Care Providers
Presentation transcript:

Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011

Counseling & Pharmacotherapy

Who Calls the Quitline? Smoked / used tobacco >20 years Not well educated Lower income Motivated to quit Confidence lower than motivation Chronic illness High nicotine dependence

Theoretical Counseling Models Environment Personal Motivation/ Confidence Why? Behavior Social Cognitive Theory Transtheoretical Stages of Change Brief Solution Focused Therapy

Counseling Tools Cognitive Behavioral Motivational Interviewing Education Modeling Skill building Reinforcement

Counseling Focus Tobacco only Counselor backgrounds Counselor training

Facilitation Goals Develop rapport and trust Get clarity on outcome goal Provide encouragement Enhance motivation and confidence Demonstrate empathy and non-judgment Engage the caller in the quitting process Demonstrate subject matter expertise

Content Goals Provide basic information about the nature of tobacco use and dependence Educate caller about what to expect when quitting Help caller create a plan to quit Teach problem-solving and coping skills Provide medication decision support Address relapse prevention

Smoke-free policies Tobacco-tax Article 14 Healthcare referral

Integrating Pharmacotherapy into Quitlines

Pharmacotherapy Medications significantly improve success rates * Includes pregnant women, smokeless tobacco users, light smokers, and adolescents. “Providers should encourage all patients attempting to quit to use effective medications for tobacco dependence treatment, except where contraindicated or for specific populations* for which there is insufficient evidence of effectiveness.”

Quit Rates for Cessation Medications Graph reprinted with permission, Rx for Change, The Regents of the University of California, University of Southern California, and Western University of Health Sciences. Percent quit

How does pharmacotherapy help people quit? Nicotine is physiologically addictive Medications help reduce cravings and withdrawal symptoms More medication => higher quit rates

Integrating Medication with Counseling in a Quitline Setting Great opportunity to combine counseling and medication to maximize quitting success Counselor training and support needs – Knowledge about medications – Protocols and algorithms – Informational tools and resources Access to medications – Options and challenges

Factors to consider in recommending pharmacotherapy All are safe, effective and well tolerated – Minor side-effects common/adverse events rare – Some use exclusions or contraindications Decision support assessment – Number of cigs per day and time to first cigarette – History of prior quit attempts/use of medication – Advantages/disadvantages of each medication – Personal preference

Pharmacotherapy Options Nicotine replacement products – Non-prescription: Patches, Gum or Lozenge – Prescription: Oral Inhaler or Nasal Spray Non-nicotine products (by prescription only) - Bupropion SR (Zyban) and Varenicline (Chantix)

Nicotine Gum (2 mg, 4 mg) Advantages May satisfy oral cravings and delay weight gain Titrate use to manage withdrawal symptoms Disadvantages Visible use Difficult with dentures or jaw problems/TMJ Must use proper technique to minimize side-effects and maximize effectiveness 2 mg for those smoking less than 25 cpd 4 mg for those smoking 25 or more cpd Patients should use ad lib but not exceed 24 pieces per day

Transdermal Nicotine Patch 21 mg for those smoking 11+ cigarettes per day 14 mg for those smoking 5-10 cigarettes per day 7 mg for those smoking 1-4 cigarettes per day Advantages Provides consistent nicotine levels Easy to use and conceal Fewer compliance issues Disadvantages Reactions to adhesive are common Cannot titrate the dose

Nicotine Lozenge (2 mg, 4 mg) 2 mg if smoke > 30 minutes after waking 4 mg if smoke within the first 30 minutes Should not exceed 20 lozenges per day Advantages May satisfy oral cravings Easy to use and conceal Titrate to manage withdrawal symptoms Disadvantages Gastrointestinal side effects (nausea, hiccups, heartburn)

Nicotine Nasal Spray Advantages Easily titrated with rapid control of withdrawal symptoms Disadvantages Nasal or throat irritation common Dependence can result Must wait 5 minutes before driving or operating heavy machinery Those with chronic nasal disorders or severe reactive airway disease should not use Rapid onset of action Doses per hour: 1-2 Maximum doses per day: 40 Maximum duration of treatment: 3 months

Nicotine Inhaler Advantages Easily titrated to rapidly manage withdrawal symptoms Mimics hand-to-mouth ritual Disadvantages Mouth and throat irritation common Absorbed through oral mucosa (not lung) 12 week course Initial dose of 6 to 16 cartridges per day Frequent continuous puffing for 20 minutes

Bupropion SR (Zyban) Start 1 week before quit date 150 mg 1x per day for 3 days 150 mg 2x per day for duration (7-12 weeks) Advantages Easy to use Can be taken with NRT May help with depression Disadvantages Seizure risk is increased Avoid or use with caution in those with history of seizures, head trauma, eating disorders or heavy alcohol use Use contraindicated with certain medications

Varenicline (Chantix or Champix) Advantages  Unique mechanism of action (partial nicotinic receptor agonist; lessens withdrawal symptoms and inhibits smoking “reward”)  Easy to use Disadvantages  Nausea common (up to 40% of users)  FDA “black box” warning  Use with caution in those with psychiatric diagnosis or history Start 1 week before quit date 0.5mg 1x per day for days mg 2x per day for days mg 2x per day for 12 weeks

Panelist Questions Counseling & Pharmacotherapy Is the model your counselors use based on practice, theory or both? Please describe your model. How does your quitline address use of medications to quit? – Do you help callers choose medications? – Do you explain how to use the medications? – Are you able provide free or low-cost access to medications? Do you have advice to offer those who are developing or expanding new quitlines?

Thank you!